Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Enefit Green Signs Loan Agreement Amendment with Swedbank
-
Enstar Completes Reinsurance Transaction with Accredited
-
Haynes International Inc. Names Marlin C. Losch III Chief Operating Officer
-
Simpson Associates recognised as the winner of 2024 Microsoft Community Response Partner of the Year
-
Onex Partners completes acquisition of Accredited
-
Form 8.3 - Keywords Studios Plc
-
KANZHUN LIMITED Announces Results of Annual General Meeting
-
ELAN Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Elanco Animal Health Incorporated for Potential Securities Law Violations
-
ELAN Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Elanco Animal Health Incorporated for Potential Securities Law Violations
-
Trading Commences in Physically-Settled LNG and Carbon Futures on Abaxx Commodity Futures Exchange and Clearinghouse
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Form 8.3 - Alpha Financial Markets Consulting Plc
-
ATTENTION NASDAQ: TWOU INVESTORS: Contact Berger Montague About a 2U, Inc. Class Action Lawsuit
-
Form 8.3 - Hargreaves Lansdown plc
-
Reborn Coffee Collaborates with Hagerty Garage + Social to Celebrate Hagerty's 40th Anniversary in South Florida
-
Reborn Coffee Collaborates with Hagerty Garage + Social to Celebrate Hagerty's 40th Anniversary in South Florida
-
Global Water Resources Declares Monthly Dividend
-
Falco Announces Resignation of Board Member
-
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
-
Cheetah Net Moves Its Headquarters to Los Angeles
-
Stran & Company Reports Preliminary Selected Unaudited Results for the First Quarter of 2024
-
Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
-
Callan JMB Inc. Supports Chicago Department of Public Health in Containing Measles Outbreak through Comprehensive Vaccine Management Plan
-
Actelis Receives Order from Major German Municipal Utilities Company
-
Safety Shot President Jordan Schur Invests $1 Million in the Company Through his Family Fund, Core 4 Capital Corp.
-
Stran & Company Reports Preliminary Selected Unaudited Results for the First Quarter of 2024
-
NANO Nuclear Energy Praises Congress for its Bipartisan Passage of the ‘ADVANCE’ Act to Boost Advanced Nuclear Technology Deployment and Strengthen U.S. Energy Independence
-
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
-
Fluent, Inc. Announces Inclusion in Russell Microcap® Index
-
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
-
Hywin Holdings Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
-
ECD Auto Design Reports First Quarter 2024 Financial Results; Revenues Increase 207% to Record $8.3 Million
-
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
-
Regency Centers Invites You to Join Its Second Quarter 2024 Earnings Conference Call
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Alliance Trust PLC - Net Asset Value
-
Form 8.3 - Mattioli Woods plc - Octopus Investments
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
VCI Global Announces Secondary Listing on the Frankfurt Stock Exchange, Expanding its Market Reach
-
Bebe Rexha Returns to Roblox with New Listening Party Through Super League's Innovative Scalable Music Offering - SOUNDZ
-
Bebe Rexha Returns to Roblox with New Listening Party Through Super League's Innovative Scalable Music Offering - SOUNDZ
-
BNP Paribas Primary New Issues: CMA NO STAB Notice
-
Powerdyne International Inc. Announces A letter to the Shareholders update
-
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndr
-
Eyenovia Announces Pricing of $5M Registered Direct Offering
-
Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
-
Minerals Technologies Announces Second Quarter 2024 Conference Call
-
Talisker Announces Results of Annual General Meeting of Shareholders
-
Genius Group Announces New Equity Research Report from Diamond Equity Research
-
International Land Alliance Announces Year End 2023 Results
